Autres langues Lin BioScience, Inc.

Actions

6696

TW0006696008

Produits pharmaceutiques

Cours en clôture Taipei Exchange 19/08/2026			Varia. 5j.	Varia. 1 janv.
93,90 ^TWD	+4,92%		0,00%	+136,52%

14/08	Lin BioScience, Inc. publie ses résultats pour le premier semestre clos le 30 juin 2026	CI
28/04	Lin BioScience, Inc. publie ses résultats pour l'exercice clos le 31 décembre 2025	CI

Autres langues

14/08	Lin BioScience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026
28/04	Lin BioScience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
26/11	Catalytic Transition Fund, managed by Brookfield Asset Management Ltd. acquired Alba Renewables Pte. Ltd. from SUSI Asia Energy Transition Fund Scsp, managed by SUSI Partners AG.
11/09/25	Gateway Partners Limited and Leafgreen Capital Pte Ltd acquired Demeter Indo Investment Pte. Ltd. from KKR & Co. Inc..
13/08/25	Lin BioScience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2025
30/04/25	Lin BioScience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
27/11/24	Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007
13/08/24	Lin BioScience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2024
23/04/24	Lin BioScience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
14/08/23	Lin BioScience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
25/04/23	Lin BioScience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
12/08/22	Lin BioScience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
25/04/22	Lin BioScience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
14/08/21	Lin Bioscience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2021
07/05/21	Lin Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
08/04/21	Lin Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
21/09/20	Lin BioScience, Inc.(GTSM:6696) added to S&P Global BMI Index
13/08/20	Lin Bioscience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2020
29/04/20	Lin Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
13/08/19	Lin Bioscience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2019
25/04/19	Lin Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018
17/09/18	US Food and Drug Administration Grants Lin BioScience Rare Pediatric Disease Status for LBS-008 to Treat Stargardt Disease